Proteomics reveals the effects of sustained weight loss on the human plasma proteomePhilipp E. Geyer, Matthias Mann, Nicolai J. Wewer Albrechtsen et al.|Molecular Systems Biology|2016Cited by 261
GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese WomenEva W. Iepsen, Signe S. Torekov, Jens‐Erik Beck Jensen et al.|The Journal of Clinical Endocrinology & Metabolism|2015Cited by 187
Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor AgonistEva W. Iepsen, Signe S. Torekov, Jinyi Zhang et al.|Cell Metabolism|2018Cited by 147
Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight lossEva W. Iepsen, Signe S. Torekov, J. Lundgren et al.|International Journal of Obesity|2014Cited by 110
Liraglutide for Type 2 diabetes and obesity: a 2015 updateEva W. Iepsen, Jens J. Holst, Signe S. Torekov|Expert Review of Cardiovascular Therapy|2015Cited by 97